General Information of the Protein
Protein ID
PT02059
Protein Name
C-X-C chemokine receptor type 4
Secondarily
Protein Name
FB22
Fusin
HM89
LCR1
Leukocyte-derived seven transmembrane domain receptor
Lipopolysaccharide-associated protein 3
NPYRL
Stromal cell-derived factor 1 receptor
Gene Name
CXCR4
Sequence
MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Peptide receptor (family A GPCR)
>
Chemokine receptor
>
CXC chemokine receptor
Function
Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing MAPK1/MAPK3 activation (PubMed:10452968, PubMed:28978524, PubMed:18799424, PubMed:24912431). Involved in the AKT signaling cascade (PubMed:24912431). Plays a role in regulation of cell migration, e.g. during wound healing (PubMed:28978524). Acts as a receptor for extracellular ubiquitin; leading to enhanced intracellular calcium ions and reduced cellular cAMP levels (PubMed:20228059). Binds bacterial lipopolysaccharide (LPS) et mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). Involved in hematopoiesis and in cardiac ventricular septum formation. Also plays an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
P61073

Secondarily ID:
B2R5N0
O60835
P30991
P56438
Q53S69
Q9BXA0
Q9UKN2
    Show/Hide
HGNC ID
HGNC:2561
Subcellular Location
Cell membrane
Cell junction
Early endosome
Late endosome
Lysosome
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000064 , Chem-1
Compound ID Compound Name Compound Formula
CP0489179
N-(pyridin-2-ylmethyl)-N'-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C29H37N5
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0406572
N'-[[(2S)-4-(4-chlorophenyl)sulfonylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C24H34ClN5O2S
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0416320
[(3S)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]piperazin-1-yl]-phenylmethanone
   Show/Hide
C25H35N5O
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0563754
N'-[[(2S)-4-(benzenesulfonyl)piperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C24H35N5O2S
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0070322
N'-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C23H32N4
 2
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
2
IC50 = 120 nM
   TI
   LI
   LO
   TS
CP0484544
4-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]butylurea
   Show/Hide
C24H33N5O
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0471105
N-[4-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]butyl]acetamide
   Show/Hide
C25H34N4O
 1
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
CP0141162
[(3R)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]piperazin-1-yl]-phenylmethanone
   Show/Hide
C25H35N5O
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0445507
N-propan-2-yl-N'-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C26H38N4
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0069850
(6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazol-3-yl)methyl N,N'-dicyclohexylimidothiocarbamate
   Show/Hide
C21H34N4S2
 1
1
IC50 = 7.4 nM
   TI
   LI
   LO
   TS
CP0466954
N,N-dimethyl-N'-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C25H36N4
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0444193
(6,6-dimethyl-5H-imidazo[2,1-b][1,3]thiazol-3-yl)methyl N'-[4-[[[2-[2-[6-[[2-[2-[[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethoxy]acetyl]amino]hexylamino]-2-oxoethoxy]acetyl]amino]methyl]cyclohexyl]-N-cyclohexylcarbamimidothioate
   Show/Hide
C56H83N9O9S2
 1
1
IC50 = 17.2 nM
   TI
   LI
   LO
   TS
CP0416321
benzyl (3S)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]piperazine-1-carboxylate
   Show/Hide
C26H37N5O2
 1
1
IC50 = 18 nM
   TI
   LI
   LO
   TS
CP0099464
N'-[[(2R)-4-(benzenesulfonyl)piperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C24H35N5O2S
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0431549
[(3R)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]piperazin-1-yl]-(furan-2-yl)methanone
   Show/Hide
C23H33N5O2
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0387864
N'-[[(3R)-2-methyl-3,4-dihydro-1H-isoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C24H34N4
 1
1
IC50 = 39 nM
   TI
   LI
   LO
   TS
CP0559064
N'-[[(2S)-4-(1-benzothiophen-2-ylsulfonyl)piperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C26H35N5O2S2
 1
1
IC50 = 39 nM
   TI
   LI
   LO
   TS
CP0444196
N'-[[(3R)-2-(pyridin-2-ylmethyl)-3,4-dihydro-1H-isoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C29H37N5
 1
1
IC50 = 56 nM
   TI
   LI
   LO
   TS
CP0425036
N'-[[(2S)-4-naphthalen-2-ylsulfonylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C28H37N5O2S
 1
1
IC50 = 71 nM
   TI
   LI
   LO
   TS
CP0443356
N'-[(4-phenylpiperazin-2-yl)methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C24H35N5
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0387771
N'-[[(3R)-2-propan-2-yl-3,4-dihydro-1H-isoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C26H38N4
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0387865
1,1-dimethyl-3-[4-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]butyl]urea
   Show/Hide
C26H37N5O
 1
1
IC50 = 180 nM
   TI
   LI
   LO
   TS
CP0125301
N'-[[(2S)-4-benzylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C25H37N5
 1
1
IC50 = 190 nM
   TI
   LI
   LO
   TS
CP0450351
N'-[[(2R)-4-benzylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C25H37N5
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0428477
N'-[[(2R)-piperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C18H31N5
 1
1
IC50 = 255 nM
   TI
   LI
   LO
   TS
CP0524752
N'-[[(3R)-2-(pyridin-3-ylmethyl)-3,4-dihydro-1H-isoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C29H37N5
 1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS
CP0387863
N'-[[(3R)-2-(1,3-oxazol-4-ylmethyl)-3,4-dihydro-1H-isoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C27H35N5O
 1
1
IC50 = 490 nM
   TI
   LI
   LO
   TS
CP0392740
2-[(3R)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-1-morpholin-4-ylethanone
   Show/Hide
C29H41N5O2
 1
1
IC50 = 570 nM
   TI
   LI
   LO
   TS
CP0432257
N'-[[(3R)-2-(pyridin-4-ylmethyl)-3,4-dihydro-1H-isoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C29H37N5
 1
1
IC50 = 660 nM
   TI
   LI
   LO
   TS
CP0528841
N'-[[(2S)-piperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C18H31N5
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0511994
(6,6-dimethyl-5H-imidazo[2,1-b][1,3]thiazol-3-yl)methyl N'-[4-[[[2-[2-[4-[[2-[2-[[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethoxy]acetyl]amino]butylamino]-2-oxoethoxy]acetyl]amino]methyl]cyclohexyl]carbamimidothioate
   Show/Hide
C48H69N9O9S2
 1
1
IC50 = 3600 nM
   TI
   LI
   LO
   TS
CP0406573
(3S)-3-[[4-aminobutyl-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]amino]methyl]-N-phenylpiperazine-1-carboxamide
   Show/Hide
C25H36N6O
 1
1
IC50 = 21000 nM
   TI
   LI
   LO
   TS
CP0564856
(6,6-dimethyl-5H-imidazo[2,1-b][1,3]thiazol-3-yl)methyl N-cyclohexyl-N'-[4-[[[2-[2-[4-[[2-[2-(methylamino)-2-oxoethoxy]acetyl]amino]butylamino]-2-oxoethoxy]acetyl]amino]methyl]cyclohexyl]carbamimidothioate
   Show/Hide
C35H58N8O6S2
 1
1
IC50 = 69000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0248152
2-[3-[(2S,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine
   Show/Hide
C36H47N11O6
 1
1 IC50 = 4 nM
CP0177564
2-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine
   Show/Hide
C36H47N11O6
 1
1 IC50 = 8 nM
CP0070322
N'-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C23H32N4
 3
1 IC50 = 15 nM
2 IC50 = 35 nM
3 IC50 = 112 nM
CP0067401
(S)-N-((1H-benzo[d]imidazol-2-yl)methyl)-N-(4-aminobutyl)-5,6,7,8-tetrahydroquinolin-8-amine
   Show/Hide
C21H27N5
 1
1 IC50 = 30 nM
CP0733906
1,4-bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene octahydrochloride
   Show/Hide
C28H62Cl8N8
 1
1 IC50 = 30 nM
CP0145769
1,1''-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}
   Show/Hide
C28H54N8
 1
1 IC50 = 74 nM
CP0125301
N'-[[(2S)-4-benzylpiperazin-2-yl]methyl]-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
   Show/Hide
C25H37N5
 1
1 IC50 = 2920 nM
CP0071651
4-[[4-(4-benzyl-1H-pyrazol-5-yl)piperidin-1-yl]methyl]pyridine
   Show/Hide
C21H24N4
 1
1 IC50 = 10000 nM
CP0649585
1-butyl-3-(2-methylpropyl)-9-(6-phenylhexyl)-1,4,9-triazaspiro-[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C28H46ClN3O2
 1
1 IC50 > 10000 nM
CP0651200
9-(1,4-benzodioxane-6-yl)-1-butyl-3-(2-methylpropyl)-1,4,9-triazaspiro[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C25H38ClN3O4
 1
1 IC50 > 10000 nM
CP0651215
9-benzyl-1-butyl-3-(2-methylpropyl)-1,4,9-triazaspiro[5.5]-undeca-2,5-dione hydrochloride
   Show/Hide
C23H36ClN3O2
 1
1 IC50 > 10000 nM
CP0657856
(+/-)-1-butyl-3-(cyclohexylmethyl)-9-(4-phenoxybenzyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochloride
   Show/Hide
C32H44ClN3O3
 1
1 IC50 > 10000 nM
CP0662025
(3R)-3-cyclohexylmethyl-9-(6-phenylhexyl)-1-propyl-1,4,9-triazaspiro[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C30H48ClN3O2
 1
1 IC50 > 10000 nM
CP0662064
9-(1,4-benzodioxane-6-yl)-1-butyl-3-cyclohexyl-1,4,9-triazaspiro-[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C28H42ClN3O4
 1
1 IC50 > 10000 nM
CP0662079
(3S)-3-cyclohexylmethyl-9-(6-phenylhexyl)-1-propyl-1,4,9-triazaspiro[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C30H48ClN3O2
 1
1 IC50 > 10000 nM
CP0720738
(+/-)-1-butyl-3-isobutyl-9-(4-phenoxybenzyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochloride
   Show/Hide
C29H40ClN3O3
 1
1 IC50 > 10000 nM
CP0837909
9-(4-allyloxyphenylmethyl)-1-butyl-3-cyclohexyl-1,4,9-triazaspiro[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C29H44ClN3O3
 1
1 IC50 > 10000 nM
CP0651202
1-butyl-3-cyclohexylmethyl-9-(4-methoxyphenylmethyl)-1,4,9-triazaspiro[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C27H42ClN3O3
 1
1 IC50 > 30000 nM
CP0699196
3-(2-methylpropyl)-9-(4-phenoxyphenylmethyl)-1-propyl-1,4,9-triazaspiro[5.5]undeca-2,5-dione hydrochloride
   Show/Hide
C28H38ClN3O3
 1
1 IC50 > 30000 nM
Clinical Information about the Protein
Target 1 ( C-X-C chemokine receptor type 4 (CXCR4) )
Target Type Successful Target
Disease 5 Target-related Diseases  5
1 Non-hodgkin lymphoma [ICD-11: 2B33.5]
2 Whim syndrome [ICD-11: 4A00.Y]
3 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
4 Human immunodeficiency virus-1 infection [ICD-11: 1C62]
5 Acute lymphoblastic leukaemia [ICD-11: 2A85]
Approved Drug(s) 1 Approved Drug  1
1 Plerixafor Approved
Non-hodgkin lymphoma
Clinical Trial Drug(s) 2 Clinical Trial Drugs  2
1 AMD-070 Phase 3
Whim syndrome
2 MSX-122 Phase 1
Solid tumour/cancer
Investigative Drug(s) 2 Investigative Drugs  2
1 GSK-812397 Investigative
Human immunodeficiency virus-1 infection
2 TN-14003 Investigative
Acute lymphoblastic leukaemia
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT06053 C-X-C chemokine receptor type 4 Rattus norvegicus, Rat